The Ospedale Maggiore "Carlo Alberto Pizzardi" belongs to the Azienda Sanitaria Locale of Bologna, together with Ospedale Bellaria "C. A. Pizzardi". It is the second biggest hospital of the city, with more than 900 beds, after the Policlinico Sant'Orsola-Malpighi.

There are 927 beds in Ospedale Maggiore.

During the past decade, Ospedale Maggiore conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 2 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Maggiore" #1 sponsor was "Abbott Medical Devices" with 2 trials, followed by "Azienda Usl di Bologna" with 2 trials sponsored, "Chiesi Farmaceutici S.p.A." with 2 trials sponsored, "Fadoi Foundation, Italy" with 2 trials sponsored and "Mario Negri Institute for Pharmacological Research" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Maggiore" #1 collaborator was "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Azienda Ospedaliera San Gerardo di Monza" with 1 trials as a collaborator, "Centre for Neonatal Research and Education, Crawley, West Australia" with 1 trials as a collaborator, "Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico" with 1 trials as a collaborator and "Heart Care Foundation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Maggiore" are "Acute Coronary Syndrome" (2 trials), "Coronary Artery Disease" (2 trials), "Coronary Artery Restenosis" (2 trials), "Coronary Artery Stenosis" (2 trials) and "Coronary Disease" (2 trials). Many other conditions were trialed in "Ospedale Maggiore" in a lesser frequency.

Most popular intervention types in "Ospedale Maggiore" are "Drug" (11 trials), "Device" (3 trials), "Diagnostic Test" (2 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Apixaban" (1 trials), "Beta blocker" (1 trials), "Bivalirudin" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Maggiore" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale Maggiore". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Ospedale Maggiore, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Maggiore, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".